Novel Technology Has Made It Possible To Diagnose A New Clinical Phenotype Of Rejection Called Early Antibody Mediated Rejection, With Significant Therapeutic Implications For Renal Allograft Survival | One Lambda

By: Christopher Lawrence In two cases with graft dysfunction and elevated cfDNA but normal or borderline biopsy findings, MMDx Kidney identified early AMBR, which responded to treatment. MMDx Kidney in addition to local histopathology findings gives clinicians increased confidence in the diagnosis and treatment of allograft dysfunction. It is suggested that early diagnosis and treatment will improve outcomes. The authors present the cases of two recent kidney transplant recipients. The first...